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ABSTRACT
Background
GPs investigate approximately half of all infertile couples
with semen analysis and endocrine blood tests. For
assessment of tubal status, hysterosalpingography (HSG)
is recommended as a first-line investigation for women
not known to have comorbidities.
Aim
To test whether providing GPs with open access to HSG
results in infertile couples progressing to a diagnosis and
management plan sooner than with usual management.
Design of study
A pragmatic cluster randomised controlled trial.
Setting
Seventy-one of 173 general practices in north-east
England agreed to participate.
Method
A total of 670 infertile couples presented to 33
intervention practices and 25 control practices over a 2-
year period. Practices allocated to the intervention group
had access to HSG for those infertile women who
fulfilled predefined eligibility criteria. The primary
outcome measure was the interval between presentation
to the GP and the couple receiving a diagnosis and
management plan.
Results
An annual incidence of 0.8 couples per 1000 total
population equated to each GP seeing an average of one
or two infertile couples each year. Open access HSG was
used for 9% of all infertile women who presented to the
intervention practices during the study period. The time
to reach a diagnosis and management plan for all infertile
couples presenting was not affected by the availability of
open access HSG (Cox regression hazard ratio = 0.9,
95% confidence interval [CI] = 0.7 to 1.1). For couples
who reached a diagnosis and management plan, there
was a non-significant difference in time to primary
outcome for intervention versus control practices (32.5
weeks versus 30.5 weeks, mean difference 2.2 weeks,
95% CI = 1.6 to 6.1 weeks, P = 0.1). The intracluster
correlation coefficient was 0.03 across all practices.
Conclusion
Providing GPs with open access to HSG had no effect
on the time taken to reach a diagnosis and management
plan for couples with infertility.
Keywords
family practice; health services accessibility;
hysterosalpingography; infertility; primary health care;
randomised controlled trial.
INTRODUCTION
Infertility affects approximately one in six couples
during their lifetime,1,2 and a GP can expect to see
one or two new infertile couples each year.1,3 GPs
usually undertake an initial assessment of male
fertility status and female ovulation status, with
assessment of tubal patency being done under
specialist care. In recent years the increasing
regulation of fertility treatments has led to services
being concentrated in dedicated tertiary care
facilities.4 Referral of infertile couples to non-licensed
units may delay access to definitive treatment. The
inclusion of assisted reproduction in national 18-
week-to-treatment targets requires a more rapid
investigation and referral pathway. Recent National
Institute for Health and Clinical Excellence (NICE)
guidelines on assessment and treatment for people
with fertility problems5 includes a recommendation
that hysterosalpingography (HSG) should be
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considered as a first-line investigation for tubal
status for women not known to have any
comorbidities.5 Direct access to HSG is
recommended for the primary assessment of infertile
couples on the NHS 18-week commissioning
pathway website.6 This may contribute to a reduction
in time from referral to definitive treatment. This
research tested whether providing GPs with open
access to HSG enabled the infertile couple to reach
a diagnosis and management plan sooner than with
usual management.
METHOD
Setting and participants
Seventy-one of the 173 practices (41%)
approached in the Newcastle upon Tyne, North
Tyneside, South Tyneside, Gateshead, and
Northumberland Primary Care Trust areas agreed to
take part. All GP principals within the practice
signed a statement of intent to participate in the
study (cluster-level consent),7 and were invited to a
local launch meeting where trial allocation was
revealed and literature, including a one-page
summary of the NICE guidance on infertility
management, was provided. Intervention practices
also received open access HSG and hospital
radiology request forms as well as patient
information leaflets for the HSG procedure. Written
consent of couples entering the trial was obtained
by their GPs (patient-level consent). Incident cases
of infertile couples presenting to their GP between
31 December 2004 and 31 December 2006 were
eligible to enter the trial. The general practice
complete electronic clinical records including
scanned correspondence from hospitals were the
primary data source for the study.
Design
This was a 1:1 cluster-randomised controlled trial
with the practices as the unit of randomisation.
Practices were stratified by geographical area.8 A
permutated block design within each stratum
ensured balanced allocation between intervention
and control practices for large (>4 whole-time
equivalent [WTE] GPs), intermediate (2–4 WTE GPs),
and small (<2 WTE GPs) GP practices. Practices
were randomly allocated, using SPSS (version 14.0),
to intervention or control by a statistician with no
prior knowledge of the practices.
Intervention
Intervention practices were able to request HSG
through an open access service if their patients
fulfilled predetermined eligibility criteria (Box 1). Use
of the investigation remained at the discretion of the
GP and the consenting woman. The open access
service was provided at the radiology department of
the Royal Victoria Infirmary, Newcastle upon Tyne (for
Northumberland, Newcastle, North Tyneside) and at
the Queen Elizabeth Hospital, Gateshead (for
Gateshead and South Tyneside). In the control
practices GPs did not have access to HSG, and
following referral the investigation was traditionally
requested by fertility specialists.
Objective
The study objective was to evaluate the effect of
providing GPs with open access to HSG on time to
diagnosis and completeness of the initial
assessment for infertile couples. The latter was
defined by the NICE recommendation which was
embedded within the open access HSG criteria
(Box 1).
Outcomes
The primary outcome was the time taken from
presentation to the GP and the couple receiving a
definitive cause and management plan for their
infertility from a fertility specialist or their GP. A
management plan was defined by the offer of
treatment, whether ovulation induction with
clomifene, in vitro fertilisation, intracytoplasmic
sperm injection, donor eggs or sperm, weight loss,
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How this fits in
In the diagnostic process of infertility, GPs do not routinely have access to
hysterosalpingography. However, women with tubal infertility identified on
hysterosalpingography require referral for in vitro fertilisation or intracytoplasmic
sperm injection at a Human Fertilisation and Embryology Authority-licensed
tertiary care fertility unit.
 The couple must have been trying to conceive for 1 year
 Normal semen analysis
 Normal coital function
 Female aged <40 years
 Regular menstrual cycle (<6 weeks)
 Day 2–5 follicle-stimulating hormone <10 IU/l
 Mid-luteal progesterone >20 nmol/l
 No history of tubal disease
 No known uterine or cervical abnormality
 Negative endocervical swabs for chlamydia and gonococcus
 Rubella status checked
 Female in receipt of folic acid
Box 1. Criteria for open access hysterosalpingography.
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intrauterine insemination, or reversal of sterilisation,
or no treatment offered. Couples with no record of
a diagnosis and/or management plan were
considered not to have reached the primary
outcome. A secondary outcome was the
completeness of the initial assessment for infertile
couples.
Sample size
Assumptions were that the data were normally
distributed with similar standard deviations, that an
average practice of three GPs would see six
couples in 1 year,1 and that 50% of all infertile
couples would be recruited to the trial, with
approximately 50% eligible for open access HSG,
giving an estimated 1.5 HSG referrals from each
practice, that is a 25% uptake of the intervention.
The estimated time to diagnosis and management
plan for controls was 26 weeks (standard deviation
173 practices
invited to join
36 intervention practices
0 practices withdrew
3 practices failed to
recruit or denied access
to the investigator
102 practices
declined
71 practices
agreed to
take part
Practice
randomised
35 control practices
4 practices withdrew
6 practices failed to
recruit or denied access
to the investigator
Allocation to intervention
373 couples (from 33
practices) presented
to the GPs
34 couples received
the intervention
Allocation to control
297 couples (from 25
practices) presented
to the GPs
Exclusions
12 historical diagnoses
176 right censored cases
a
b
Exclusions
13 historical diagnoses
151 right censored cases
a
b
185 couples in final analysis 133 couples in final analysis
Figure 1. Practices and
participant flow.
a25 couples excluded. This is a known study bias discussed in the Results section. A total of 327 couples did not reach
the primary outcome measure (time from presentation to GP, to reaching a diagnosis and management plan) due to either
spontaneous pregnancy, still being under investigation, or withdrawing from management.
[SD] 14 weeks).3 With a best estimate for the
intracluster correlation coefficient of 0.01,9,10 to
detect a 30% (26 weeks to 18 weeks) reduction in
primary outcome with 80% power and 5%
significance level, 36 practices (54 couples or 216
assuming 25% uptake) would be required in each
arm of the trial.
Statistical methods
Data were analysed using SPSS and MLwiN. A
survival analysis using a Cox proportional hazards
model11 was used to account for couples that had
not reached the primary outcome measure. For
couples that reached the primary outcome measure,
a cluster analysis using multilevel modelling (MLwiN)
was employed.12 The effect of clustering was
quantified using patient- and practice-level variances
and presented as the intracluster correlation
coefficient for the primary outcome measure.
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Adjusted mean differences between groups are
presented with 95% confidence intervals (CI), and
P<0.05 was considered significant.
Secondary analyses on the primary outcome were
adjusted for the effect of geographical area, use of
open access HSG, and place of referral.
Secondary outcomes were a measure of the
uptake of open access HSG and a logistic regression
model for binomial response data (investigations
performed in both groups), adjusting for patient
clustering.
RESULTS
Participant flow
There were 670 incident couples over the 2-year
period from 58 practices (Figure 1), with a combined
list size of 403 263 patients (72 182 being women
aged 16–42 years). This represents an annual
incidence of 0.8 infertile couples per 1000 total
population, or 4.6 couples per 1000 women aged
16–42 years. Characteristics of the trial participants
are shown in Table 1.
Initial investigations recommended by the NICE
guideline, that is, semen analysis, mid-luteal
progesterone, and follicle-stimulating hormone
(FSH), were done for between half and two-thirds of
couples. Of those couples referred (479/670), GPs
were most efficient at passing on information about
the length of time a couple were trying to conceive,
their fertility status, menstrual cycle status, and mid-
luteal progesterone result (Table 2).
Primary outcome
The time from first presentation to diagnosis and
management plan comprises three elements: time
from presentation to the GP to being referred, time
from referral to being seen by the fertility specialist,
and time from being seen by the fertility specialist to
the couple receiving a diagnosis and management
plan. In this study these intervals were 7.1 weeks
(SD = 9.7), 9.7 weeks (SD = 4.4), and 14.3 weeks (SD
= 13.6) respectively. Three per cent (11/343) of
couples were given a diagnosis and management
plan by their GP.
For all couples (n = 670), a Kaplan–Meier survival
analysis and Cox regression/proportional hazards
model (hazard ratio 0.9, 95% CI = 0.7 to 1.1, P = 0.3)
demonstrated a non-significant difference between
intervention and control couples reaching the
primary outcome (Figure 2). A definitive diagnosis
and management plan was reached by 343 (51%)
couples (Table 3). Twenty-five couples (12 from
intervention and 13 from control) who had an
historical diagnosis were excluded, leaving 318
couples (133 control and 185 intervention) in the
final analysis.
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Intervention Control Total
n = 373 n = 297 n = 670
Age of female: years, mean (SD) 30 (6) 31 (6) 31 (6)
Trying to conceive: months, mean (SD) 24 (15) 23 (15) 23 (15)
Primary infertility: female, n (%) 207 (56) 175 (59) 382 (57)
Couple fertility status, n (%)
Primary infertilitya 171 (46) 150 (51) 321 (48)
Secondary infertilityb 104 (28) 82 (28) 186 (28)
Tertiary infertilityc
Female primary and male secondary 35 (9) 26 (9) 61 (9)
Female secondary and male primary 30 (8) 21 (7) 51 (8)
Both secondary, other union 31 (8) 18 (6) 49 (7)
Referred by GP: total, n (%) 266 (71) 213 (72) 479 (72)
To tertiary care NHSd, n (% of total referred) 135 (36) 116 (39) 251 (37)
To secondary care NHSe, n (% of total referred) 116 (31) 85 (29) 201 (30)
Privately 15 (4) 12 (4) 27 (4)
aPrimary infertility: having never had a child following 12 months’ unprotected intercourse.
bSecondary infertility: difficulty conceiving after already having a child. cTertiary infertility: difficulty
conceiving after one or both partners already have a child in a previous union. dTertiary care: fertility
services licensed by the Human Fertilisation and Embryology Authority to delivery specialist
services including in vitro fertilisation and intracytoplasmic sperm injection. eSecondary care:
general gynaecology services not licensed by the Human Fertilisation and Embryology Authority.
Table 1. Characteristics of the trial participants.
Intervention Control
GP record Referral letter GP record Referral letter
n = 373 n = 266 n = 297 n = 213
Information recorded
Length of time trying 373 (100) 205 (77) 297 (100) 141 (66)
Fertility statusa 373 (100) 168 (63) 297 (100) 93 (44)
Cycle status recorded 281 (75) 144 (54) 196 (66) 103 (48)
<42-week cycle 236 (63) 115 (43) 173 (58) 87 (41)
Folate supplementation 150 (40) 41 (15) 93 (31) 19 (9)
Recorded comorbiditiesb 78 (21) 44 (17) 56 (19) 35 (16)
Smoking status recorded 59 (16) 23 (9) 37 (12) 17 (8)
Alcohol status recorded 42 (11) 15 (6) 24 (8) 10 (5)
Frequency of intercourse 35 (9) 7 (3) 23 (8) 9 (4)
Information on tubal status 18 (5) 14 (5) 9 (3) 7 (3)
Testicular advice given 6 (2) 3 (1) 0 0
Advice regarding drugs 3 (1) 1 1 1
Investigations recorded
Mid-luteal progesterone 258 (69)c 149 (56) 208 (70)c 112 (53)
FSH/LH 220 (59)d 113 (42) 168 (57)d 88 (41)
Semen analysis 200 (54)e 120 (45) 152 (51)e 92 (43)
Thyroid function tests 172 (46) 72 (27) 154 (52) 64 (30)
Full blood count 153 (41) 61 (23) 111 (37) 44 (21)
Prolactin 92 (25) 39 (15) 70 (24) 30 (14)
Rubella 75 (20) 38 (14) 60 (20) 27 (13)
Random blood glucose 58 (16) 21 (8) 40 (13) 16 (8)
Chlamydia 62 (17) 27 (10) 23 (8) 7 (3)
Oestrogen 13 (3) 6 (2) 14 (5) 7 (3)
Testosterone 40 (11) 12 (5) 21 (7) 11 (5)
Other 79 (21) 12 (5) 58 (20) 18 (8)
aPrimary, secondary, or tertiary infertility. bObesity 28%, polycystic ovary syndrome 25%, tubal
pathology 22%, vasectomy 10%, chlamydia 5%, other 10%. cAdjusted odds ratio (OR) = 1.1, P =
0.3. dAdjusted OR = 1.1, P = 0.3. eAdjusted OR = 1.1, P = 0.3. Other investigations included urea
and electrolytes, liver function tests, sex hormone-binding globulin, and ultrasound scan. FSH =
follicle-stimulating hormone. LH = luteinising hormone.
Table 2. Information recorded on GP medical record and
referral letter; number (%).
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Multilevel modelling on couples reaching
outcome (n = 318 couples)
The intracluster correlation coefficient was 0.03
across all practices. There was a non-significant
difference in time to primary outcome for intervention
versus control practices (32.5 versus 30.3 weeks,
mean difference 2.2 weeks, 95% CI = –1.6 to 6.1
weeks, P = 0.1).
Secondary analyses on the primary outcome:
factors influencing time to definitive
diagnosis and management plan
There were significant differences between areas; the
average time to definitive diagnosis and
management plan varied from 27.8 weeks
(Gateshead) to 34.8 weeks (Northumberland).
Thirty-four couples underwent open access HSG.
Mean time to primary outcome was 22.0 weeks
compared to 32.5 weeks for couples that did not
have open access HSG (mean difference
–10.5 weeks, 95% CI = –16.4 to –4.6 weeks,
P<0.001). Two-thirds of couples that had open
access HSG performed (23/34) were subsequently
referred. For all couples referred in the trial (n = 479),
the completeness of information passed on in the
referral letter was greater for patients who had
undergone HSG (Table 4); however, this was not
statistically significant given the small numbers in the
open access HSG group. When compared with
referrals to tertiary fertility units, referrals to
secondary care took 8.7 weeks longer (95% CI = 5.2
to 12.2 weeks) to reach the primary outcome
measure, but couples referred privately reached the
outcome 8.3 weeks sooner (95% CI = –17.7 to
0.8 weeks).
Secondary outcomes
The uptake of open access HSG in the intervention
practices was 9% (34/361). Intervention practices
were no more likely than control practices to perform
the initial investigations recommended by NICE
guidance; semen analysis (adjusted odds ratio [OR]
1.1, 95% CI = –0.5 to 2.7, P = 0.3), mid-luteal
progesterone (adjusted OR = 1.1, 95% CI = –0.5 to
2.7, P = 0.3), and serum FSH (adjusted OR = 1.1,
95% CI = –0.3 to 2.7, P = 0.3); (Table 2).
DISCUSSION
Summary of main findings
Making HSG available to GPs did not decrease the
time taken for couples to reach a definitive diagnosis
and management plan. Nine per cent of couples in
the intervention arm of the study were referred for
open access HSG, and these couples reached a
diagnosis and management plan 12 weeks earlier
compared with usual management. One-third of
couples that had open access HSG performed were
not subsequently referred as the GPs adopted a
process of ‘watchful waiting’ with a diagnosis of
unexplained infertility. For couples that had open
access HSG performed, the guidance on initial
investigations embedded within the form increased
the likelihood that they were completed. Only 3% of
the variation in primary outcome can be explained by
clustering within practices, with most of the variation
occurring at the patient level, showing that there is
consistency of fertility management between
practices.
Strengths and limitations of the study
This was a pragmatic trial that gives a measure of
the usefulness of open access HSG in usual clinical
practice. By randomising practices rather than
individual GPs, contamination bias and selection
bias were minimised. However, a high dropout rate
333
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Intervention Control Total
n = 373 n = 297 n = 670
Reached primary outcome measurea 197 (53) 146 (49) 343 (51)
Spontaneous pregnancy 68 (18) 70 (24) 138 (21)
Incomplete investigations 74 (20) 63 (21) 137 (20)
Withdrew from investigations 34 (9) 18 (6) 52 (8)
a12 couples in intervention and 13 couples in control had historical diagnoses, hence reached the
outcome immediately upon consultation.
Table 3. Outcomes of infertile couples presenting to GPs;
number (%).
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Figure 2. Kaplan-Meier
survival curve: probability
of reaching the primary
outcome — intervention
versus control.
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of control practices may have contributed to a post-
randomisation selection bias. Stratification
minimised biases due to differential access and
referral patterns. Following practice randomisation,
differential recruitment within intervention and
control clusters remained an ever present threat.
There was low uptake of open access HSG by the
intervention practices, which diluted its effect size.
The secondary per protocol ‘on treatment’ analysis
was underpowered and biased. Those that received
open access HSG and were subsequently referred,
not surprisingly, had better information transferred in
the referral letter, which probably reflected individual
GP interest in fertility management.
Comparison with existing literature
The incidence (one couple per 1000 population)1,13
and management of infertility in primary care has
remained largely unchanged over the last
10 years.3,14–16 One survey has shown that 60–80%
of GPs agree that the initial investigations
recommended by the Royal College of
Obstetricians and Gynaecologists and
subsequently by NICE should be carried out in
primary care.17 Clinical guidelines alone, however,
are generally insufficient to influence GPs’
behaviour and referral patterns,18–21 and the
implementation of guidelines should be tailored to
identify potential barriers.22 Two studies on infertility
guidelines have shown a modest improvement in
GP referral patterns,23,24 although this change in
behaviour was not sustained.15 Embedding clinical
guidelines within the open access referral process
has been shown to increase compliance with
referral standards and improved service efficiency
for open access gastroscopy and open access
urological investigations.25,26 The uptake of open
access HSG was low in this study, with only 9% of
couples being referred. Data that became available
during this study suggested that 26% of couples
presenting to GPs could be eligible for open access
HSG based on this study’s criteria.27
Implications for future research and clinical
practice
Some GPs have shown a willingness to use criteria-
driven open access HSG, enabling a management
plan to be established at the first specialist
consultation. In this study, 9% of couples benefited
from open access HSG and reduced the duration of
their ‘patient journey’ from presentation to the GP to
specialist treatment, although this still fell short of the
government 18-week target.28 If open access HSG is
introduced for GPs, future research will need to
assess its impact on the whole patient journey,
referral patterns, and cost-effectiveness.
Funding body
We would like to acknowledge the NHS National
Coordinating Centre for Research Capacity Development
who funded this work through a National Institute for Health
Research (NIHR) award held by Dr Scott Wilkes (RDA03/26);
Primary Care Researcher Development Award, National
Coordinating Centre for Research Capacity Development,
Leeds Innovation Centre. All researchers involved in the
production of this paper are independent from the funder.
The trial is Current Controlled Trials ISRCTN18398372
Ethics committee
Ethical approval was granted from Newcastle and North
Tyneside as the main REC with SSA approval from
Northumberland, Gateshead, and South Tyneside Local
Research Ethics Committees. Approval was also granted
from Sunderland University Research Ethics Committee
Competing interests
The authors have stated that there are none
Acknowledgements
Academics within Sunderland University contributed to the
study design; collection, analysis, and interpretation of data;
production of the paper and the decision to submit the
article for publication.
Discuss this article
Contribute and read comments about this article on the
Discussion Forum: http://www.rcgp.org.uk/bjgp-discuss
REFERENCES
1. Hull MG, Glazener CM, Kelly NJ, et al. Population study of causes,
treatment, and outcome of infertility. Br Med J (Clin Res Ed) 1985;
291(6510): 1693–1697.
2. Templeton A, Fraser C, Thompson B. The epidemiology of infertility
in Aberdeen. BMJ 1990; 301(6744): 148–152.
3. Wilkes S, Jones K. Retrospective review of the prevalence and
management of infertility in women in one practice over a five year
period. Br J Gen Pract 1995; 45(391): 75–77.
4. Human Fertilisation and Embryology Authority Newsletter. Should
embryo screening help parents prevent passing on a wider range of
inheritable diseases? http://www.hfea.gov.uk/docs/HFEA_Update_
Nov_05.pdf (accessed 6 Apr 2009).
5. National Institute for Clinical Excellence. Fertility: assessment and
treatment for people with fertility problems. London, National
Institute for Clinical Excellence, 2004; 1–45.
Referrals following Referred directly
open access HSG to hospital
n = 23 n = 456
Advice
Frequency of sexual intercourse 2 (9) 14 (3)
Avoiding testicular hyperthermia 0 3 (0)
Smoking 3 (13) 37 (8)
Alcohol 1 (4) 24 (5)
Recreational drug use 0 2 (0)
Information
Comorbidities 2 (9) 77 (17)
Rubella status 10 (43) 55 (12)
In receipt of folic acid 14 (61) 46 (10)
Investigations
Semen analysis 23 (100) 189 (41)
Mid-luteal progesterone 23 (100) 238 (52)
Follicle stimulating hormone 22 (96) 179 (39)
Thyroid function test 6 (26) 130 (29)
Prolactin 6 (26) 63 (14)
Table 4. Information recorded in the referral letter for all 479
couples referred in the trial; number (%).
British Journal of General Practice, May 2009
6. Department of Health. Delivering the 18 week patient pathway.
http://www.18weeks.nhs.uk (accessed 20 January 2009).
7. Campbell MK, Grimshaw JM. Cluster randomised trials: time for
improvement. The implications of adopting a cluster design are still
largely being ignored. BMJ 1998; 317(7167): 1171–1172.
8. Medical Research Council. Cluster randomised trials: methodological
and ethical considerations. London: Medical Research Council, 2002.
9. Adams G, Gulliford MC, Ukoumunne OC, et al. Patterns of intra-
cluster correlation from primary care research to inform study
design and analysis. J Clin Epidemiol 2004; 57(8): 785–794.
10. Campbell MK, Mollison J, Grimshaw JM. Cluster trials in
implementation research: estimation of intracluster correlation
coefficients and sample size. Stat Med 2001; 20(3): 391–399.
11. Bland M. An introduction to medical statistics. Oxford: Oxford
University Press, 1996.
12. Campbell MK, Mollison J, Steen N, et al. Analysis of cluster
randomized trials in primary care: a practical approach. Fam Pract
2000; 17(2): 192–196.
13. Oakley L, Doyle P, Maconochie N, et al. Lifetime prevalence of
infertility and infertility treatment in the UK: results from a
population-based survey of reproduction. Hum Reprod 2008; 23(2):
447–450.
14. Das S, Chin KA. A study of pre-referral evaluation of infertile
couples. J Obstet Gynaecol 2003; 23(1): 70.
15. Morrison C, Bhattacharya S, Hamilton M, et al. Initial management
of infertility: an audit of pre-referral investigations and exploration
of couples’ views at the interface of primary and secondary care.
Hum Fertil 2007; 10(1): 25–31.
16. Nicopoullos JD, Croucher CA. Audit of primary care and initial
secondary care investigations set against RCOG guidelines as
standard in cases of subfertility. J Obstet Gynaecol 2003; 23(4):
397–401.
17. Souter VL, Penney G, Gorman DR. A survey of infertility practices
in primary care in Scotland. Br J Gen Pract 1997; 47(424): 727–728.
18. Grimshaw J, Shirran E, Thomas R, et al. Getting evidence into
practice. Eff Health Care 1999; 5: 1–16.
19. Grol R. Personal paper. Beliefs and evidence in changing clinical
practice. BMJ 1997; 315(7105): 418–421.
20. Robertson N, Baker R, Hearnshaw H. Changing the clinical
behavior of doctors: a psychological framework. Qual Health Care
1996; 5(1): 51–54.
21. Wensing M, van der Weijden T, Grol R. Implementing guidelines
and innovations in general practice: which interventions are
effective? Br J Gen Pract 1998; 48(427): 991–997.
22. Bosch M, van der Weijden T, Wensing M, et al. Tailoring quality
improvement interventions to identified barriers: a multiple case
analysis. J Eval Clin Pract 2007; 13(2): 161–168.
23. Emslie C, Grimshaw J, Templeton A. Do clinical guidelines improve
general practice management and referral of infertile couples? BMJ
1993; 306(6894): 1728–1731.
24. Morrison J, Carroll L, Twaddle S, et al. Pragmatic randomised
controlled trial to evaluate guidelines for the management of
infertility across the primary care–secondary care interface. BMJ
2001; 322(7294): 1282–1284.
25. Thomas RE, Grimshaw JM, Mollison J, et al. Cluster randomized
trial of a guideline-based open access urological investigation
service. Fam Pract 2003; 20(6): 646–654.
26. Zuccaro GJ, Provencher K. Does an open access system properly
utilize endoscopic resources? Gastrointest Endosc 1997; 46(1): 15–20.
27. Wilkes S, Murdoch A, Rubin G, et al. Investigation of infertility
management in primary care with open access
hysterosalpingography (HSG): a pilot study. Hum Fertil 2006; 9(1):
47–51.
28. Department of Health. The NHS improvement plan: putting people
at the heart of public services. London: Department of Health, 2004.
335
Original Papers
